Abstract
High mortality due to CVD in CR might be caused by insufficient influencing of risk factors including alimentation patterns. Outcomes of the Euroaspire III study show, that during a certain period 1/2 of high-risk patients still suffer from hypertension and hypercholesterolemia and 1/5 of them are still active smokers, even BMI increased.
The main presumption of positive change is a motivated patient and the individualization of treatment. The problem needs to be solved by systemic approach.
In the CR a new amendment of notice was issued, which specifies content and schedule of preventive check-ups, extending the options of screening of lipids and glycemia. Though the non-pharmaceutical intervention is problematic due to lack of co-operation of the patients, it is still the most efficient, cheapest and safest way to decrease the risk.